PACBPACIFIC BIOSCIENCES OF CALI...

Nasdaq pacb.com


$ 1.46 $ -0.13 (-8.13 %)    

Tuesday, 27-Aug-2024 15:59:59 EDT
QQQ $ 476.56 $ 1.42 (0.3 %)
DIA $ 412.95 $ 0.17 (0.04 %)
SPY $ 561.57 $ 0.77 (0.14 %)
TLT $ 97.97 $ -0.17 (-0.17 %)
GLD $ 233.38 $ 0.63 (0.27 %)
$ 1.47
$ 1.57
$ 1.46 x 3,390
$ 1.47 x 15,300
$ 1.46 - $ 1.60
$ 1.16 - $ 11.96
6,774,673
na
400.62M
$ 2.27
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-09-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 02-28-2024 12-31-2023 10-K
4 11-03-2023 09-30-2023 10-Q
5 08-04-2023 06-30-2023 10-Q
6 05-04-2023 03-31-2023 10-Q
7 02-28-2023 12-31-2022 10-K
8 11-08-2022 09-30-2022 10-Q
9 08-05-2022 06-30-2022 10-Q
10 05-06-2022 03-31-2022 10-Q
11 02-28-2022 12-31-2021 10-K
12 11-05-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-06-2021 03-31-2021 10-Q
15 02-26-2021 12-31-2020 10-K
16 11-03-2020 09-30-2020 10-Q
17 08-06-2020 06-30-2020 10-Q
18 05-08-2020 03-31-2020 10-Q
19 02-28-2020 12-31-2019 10-K
20 11-07-2019 09-30-2019 10-Q
21 08-06-2019 06-30-2019 10-Q
22 05-03-2019 03-31-2019 10-Q
23 02-26-2019 12-31-2018 10-K
24 11-05-2018 09-30-2018 10-Q
25 08-03-2018 06-30-2018 10-Q
26 05-02-2018 03-31-2018 10-Q
27 02-26-2018 12-31-2017 10-K
28 11-02-2017 09-30-2017 10-Q
29 08-02-2017 06-30-2017 10-Q
30 05-05-2017 03-31-2017 10-Q
31 03-06-2017 12-31-2016 10-K
32 11-04-2016 09-30-2016 10-Q
33 08-04-2016 06-30-2016 10-Q
34 05-05-2016 03-31-2016 10-Q
35 03-11-2016 12-31-2015 10-K
36 11-05-2015 09-30-2015 10-Q
37 08-05-2015 06-30-2015 10-Q
38 05-05-2015 03-31-2015 10-Q
39 03-12-2015 12-31-2014 10-K
40 11-05-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 stephens--co-maintains-overweight-on-pacific-biosciences-lowers-price-target-to-25

Stephens & Co. analyst Mason Carrico maintains Pacific Biosciences (NASDAQ:PACB) with a Overweight and lowers the price ...

 morgan-stanley-maintains-equal-weight-on-pacific-biosciences-lowers-price-target-to-2

Morgan Stanley analyst Tejas Savant maintains Pacific Biosciences (NASDAQ:PACB) with a Equal-Weight and lowers the price tar...

 cantor-fitzgerald-reiterates-overweight-on-pacific-biosciences-maintains-35-price-target

Cantor Fitzgerald analyst Ross Osborn reiterates Pacific Biosciences (NASDAQ:PACB) with a Overweight and maintains $3.5 pric...

 canaccord-genuity-maintains-buy-on-pacific-biosciences-lowers-price-target-to-3

Canaccord Genuity analyst Kyle Mikson maintains Pacific Biosciences (NASDAQ:PACB) with a Buy and lowers the price target fro...

 pacific-biosciences-q2-2024-adj-eps-020-beats-023-estimate-sales-36013m-miss-40878m-estimate

Pacific Biosciences (NASDAQ:PACB) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $...

 dow-rallies-to-all-time-highs-small-caps-outperform-tech-gold-hits-records-on-heightened-september-rate-cut-bets-whats-driving-markets-tuesday

Wall Street continues to experience a series of memorable days, with the bulls riding the rally with increasing confidence, cer...

 pacbio-and-colors-releases-hifi-long-read-variant-database

Consortium Delivers Publicly Available Datasets that Enrich Detection of Rare and Novel Genetic Variants for Advances in Human ...

 jefferies-initiates-coverage-on-pacific-biosciences-with-buy-rating-announces-price-target-of-4

Jefferies analyst Tycho Peterson initiates coverage on Pacific Biosciences (NASDAQ:PACB) with a Buy rating and announces Pri...

 cathie-woods-ark-innovation-etf-sees-sharp-decline-among-top-holdings--here-are-10-largest-losers-within-arkf

Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showcasing the challenges faced b...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION